Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: white soft paraffin; propylene glycol; propylene glycol monostearate; white beeswax - for the relief of the inflammatory and pruritic manifestations of resistant or severe corticosteroid responsive dermatoses. these include atopic eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus and psoriasis. diprosone ov ointment is also indicated for the maintenance of remission in chronic psoriasis.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone valerate, quantity: 0.244 mg/g - cream - excipient ingredients: purified water; sodium hydroxide; chlorocresol; cetostearyl alcohol; cetomacrogol 1000; phosphoric acid; white soft paraffin; liquid paraffin; monobasic sodium phosphate dihydrate - indications as at 30 april 1991: for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritus, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, stasis dermatitis and psoriasis. celestone -m is indicated for maintenance therapy.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - betamethasone dipropionate 0.065% equivalent to 0.05% betamethasone;   - topical cream - 0.05 % - active: betamethasone dipropionate 0.065% equivalent to 0.05% betamethasone   excipient: carbomers propylene glycol purified water sodium hydroxide titanium dioxide

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - betamethasone dipropionate 0.064 mg/g equivalent to 0.5 mg betamethasone dipropionate;   - topical ointment - 0.05% w/w - active: betamethasone dipropionate 0.064 mg/g equivalent to 0.5 mg betamethasone dipropionate   excipient: propylene glycol propylene glycol monostearate white beeswax white soft paraffin

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone valerate, quantity: 0.244 mg/g (equivalent: betamethasone, qty 0.2 mg/g) - cream - excipient ingredients: liquid paraffin; purified water; chlorocresol; cetostearyl alcohol; phosphoric acid; monobasic sodium phosphate dihydrate; cetomacrogol 1000; sodium hydroxide; white soft paraffin - antroquoril is indicated for maintenance therapy for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritis, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, statis dermatitis and psoriasis. indications as at 16 august 1999: antroquoril is indicated for maintenance therapy for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritus, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, stasis dermatitis and psoriasis

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

betamethasone valerate -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

betamethasone dipropionate -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - betamethasone dipropionate -

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: white soft paraffin; liquid paraffin - indications as at 22 november 1995: diprosone is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - lidocaine, quantity: 50 mg/g - gel - excipient ingredients: macrogol 300; macrogol 4000; saccharin; cetrimide; flavour - topical anaesthetic for the oral mucosa for use in children and adults to assist during dental procedures. desensitises the mucous membranes prior to injections. surface anaesthesia for the extirpation of deciduous teeth. abscess incisions below the mucous membrane. extraction of teeth with advanced periodontitis, allows adjustment and fitting of crowns and bridges. allows juxtagingival scaling.